scholarly journals Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Trine Lisberg Toft-Bertelsen ◽  
Mads Gravers Jeppesen ◽  
Eva Tzortzini ◽  
Kai Xue ◽  
Karin Giller ◽  
...  

AbstractThe dire need for COVID-19 treatments has inspired strategies of repurposing approved drugs. Amantadine has been suggested as a candidate, and cellular as well as clinical studies have indicated beneficial effects of this drug. We demonstrate that amantadine and hexamethylene-amiloride (HMA), but not rimantadine, block the ion channel activity of Protein E from SARS-CoV-2, a conserved viroporin among coronaviruses. These findings agree with their binding to Protein E as evaluated by solution NMR and molecular dynamics simulations. Moreover, we identify two novel viroporins of SARS-CoV-2; ORF7b and ORF10, by showing ion channel activity in a X. laevis oocyte expression system. Notably, amantadine also blocks the ion channel activity of ORF10, thereby providing two ion channel targets in SARS-CoV-2 for amantadine treatment in COVID-19 patients. A screen of known viroporin inhibitors on Protein E, ORF7b, ORF10 and Protein 3a from SARS-CoV-2 revealed inhibition of Protein E and ORF7b by emodin and xanthene, the latter also blocking Protein 3a. This illustrates a general potential of well-known ion channel blockers against SARS-CoV-2 and specifically a dual molecular basis for the promising effects of amantadine in COVID-19 treatment. We therefore propose amantadine as a novel, cheap, readily available and effective way to treat COVID-19.

2018 ◽  
Vol 31 (12) ◽  
pp. 1332-1338 ◽  
Author(s):  
Rong Xu ◽  
Yuan Xiao ◽  
Yan Liu ◽  
Bo Wang ◽  
Xing Li ◽  
...  

2007 ◽  
Vol 93 (4) ◽  
pp. L20-L22 ◽  
Author(s):  
Yevgen O. Posokhov ◽  
Philip A. Gottlieb ◽  
Michael J. Morales ◽  
Frederick Sachs ◽  
Alexey S. Ladokhin

1997 ◽  
Vol 78 (6) ◽  
pp. 3371-3385 ◽  
Author(s):  
Victoria Booth ◽  
John Rinzel ◽  
Ole Kiehn

Booth, Victoria, John Rinzel, and Ole Kiehn. Compartmental model of vertebrate motoneurons for Ca2+-dependent spiking and plateau potentials under pharmacological treatment. J. Neurophysiol. 78: 3371–3385, 1997. In contrast to the limited response properties observed under normal experimental conditions, spinal motoneurons generate complex firing patterns, such as Ca2+-dependent regenerative spiking and plateaus, in the presence of certain neurotransmitters and ion-channel blockers. We have developed a quantitative motoneuron model, based on turtle motoneuron data, toinvestigate the roles of specific ionic currents and the effects of their soma and dendritic distribution in generating these complex firing patterns. In addition, the model is used to explore the effects of multiple ion channel blockers and neurotransmitters that are known to modulate motoneuron firing patterns. To represent the distribution of ionic currents across the soma and dendrites, the model contains two compartments. The soma compartment, representing the soma and proximal dendrites, contains Hodgkin-Huxley-like sodium ( I Na) and delayed rectifier K+ ( I K−dr) currents, an N-like Ca2+ current ( I Ca−N), and a calcium-dependent K+ current [ I K(Ca)]. The dendritic compartment, representing the lumped distal dendrites, contains, in addition to I Ca−N and I K(Ca) as in the soma, a persistent L-like calcium current ( I Ca−L). We determined kinetic parameters for I Na, I K−dr, I Ca−N, and I K(Ca) in order to reproduce normal action-potential firing observed in turtle spinal motoneurons, including fast and slow afterhyperpolarizations (AHPs) and a linear steady-state frequency-current relation. With this parameter set as default, a sequence of pharmacological manipulations were systematically simulated. A small reduction of I K−dr [mimicking the experimental effect of tetraethylammonium (TEA) in low concentration] enhanced the slow AHP and caused calcium spiking (mediated by I Ca−N) when I Na was blocked. Firing patterns observed experimentally in high TEA [and tetrodotoxin (TTX)], namely calcium spikes riding on a calcium plateau, were reproduced only when both I K−dr and I K(Ca) were reduced. Dendritic plateau potentials, mediated by I Ca−L, were reliably unmasked when I K(Ca) was reduced, mimicking the experimental effect of the bee venom apamin. The effect of 5-HT, which experimentally induces the ability to generate calcium-dependent plateau potentials but not calcium spiking, was reproduced in the model by reducing I K(Ca) alone. The plateau threshold current level, however, was reduced substantially if a simultaneous increase in I Ca−L was simulated, suggesting that serotonin (5-HT) induces plateau potentials by regulating more than one conductance. The onset of the plateau potential showed significant delays in response to near-threshold, depolarizing current steps. In addition, the delay times were sensitive to the current step amplitude. The delay and its sensitivity were explained by examining the model's behavior near the threshold for plateau onset. This modeling study thus accurately accounts for the basic firing behavior of vertebrate motoneurons as well as a range of complex firing patterns invoked by ion-channel blockers and 5-HT. In addition, our computational results support the hypothesis that the electroresponsiveness of motoneurons depends on a nonuniform distribution of ionic conductances, and they predict modulatory effects of 5-HT and properties of plateau activation that have yet to be tested experimentally.


1998 ◽  
Vol 41 (6) ◽  
pp. 1006-1006
Author(s):  
Lain-Yen Hu ◽  
Junqing Guo ◽  
Sharad S. Magar ◽  
James B. Fischer ◽  
Kathleen J. Burke-Howie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document